Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Smith Stan. Director active across 1 company, notably MAIA Biotechnology, Inc.. Cumulatively, 34 reports have been recorded. Breakdown: 34 buys · 0 sell. Total volume traded: €2.5m. Activity tracked since 1 August 2022. The latest transaction was disclosed on 22 December 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Smith Stan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
228 shares@ US$4.490.0% of flowCommon StockSEC:0001127602-23-006606:0
Canonical exit: 22 May 2023 (T+90)
25 of 34 declarations
About Smith Stan
Smith Stan is a declarant who has made 28 filings in total. In his most recent filings, he acquired shares of MAIA Biotechnology, Inc. for a total amount of 2,361,772 EUR, with the first transaction recorded on August 2, 2022, and the last on May 12, 2025. Notable transactions include a purchase of 974,529.99 EUR on August 2, 2022, and another of 279,048.94 EUR on April 26, 2024.